Angel Casado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Angel Casado has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Miguel A. Alvarez
Molecular Microbiology Group, Dairy Research Institute (IPLA, CSIC), Oviedo, 33011, Spain; Molecular Microbiology Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Asturias, 33011, Spain
6 shared publications - Victor Ladero
Dairy Research Institute (IPLA-CSIC), Paseo Rio Linares s/n, 33300 Villaviciosa, Spain
5 shared publications - Beatriz del Rio
Molecular Microbiology Group, Dairy Research Institute (IPLA, CSIC), Oviedo, 33011, Spain; Molecular Microbiology Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Asturias, 33011, Spain
3 shared publications - Begoña Redruello
Molecular Microbiology Group, Dairy Research Institute (IPLA, CSIC), Oviedo, 33011, Spain; Molecular Microbiology Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Asturias, 33011, Spain
2 shared publications - María Fernández
Instituto de Productos Lácteos de Asturias, IPLA-CSIC, Paseo Rio Linares s/n, 33300 Villaviciosa, Spain
2 shared publications - Carlos Rodríguez-Lucas
Servicio de Microbiología, Hospital Universitario de Cabueñes, Gijón, Spain
1 shared publication
Latest Publications
- Open Access
- 14 June 2026
- Published by Elsevier in Food Bioscience
- Vol. 82
Unraveling β-phenylethylamine production in Enterococcus durans: Towards the development of functional dairy foods
- 14 June 2026
- Published by Elsevier in Food Bioscience
- Vol. 82
Open AccessUnraveling β-phenylethylamine production in Enterococcus durans: Towards the development of functional dairy foods
- Open Access
- 12 June 2026
- Published by Elsevier in Applied Food Research
- Vol. 6 (2)
Hafnia paralvei of dairy origin as a functional adjunct culture for in situ agmatine production in yoghurt-type products
- 12 June 2026
- Published by Elsevier in Applied Food Research
- Vol. 6 (2)
Open AccessHafnia paralvei of dairy origin as a functional adjunct culture for in situ agmatine production in yoghurt-type products
- Open Access
- 18 March 2026
- Published by Elsevier in Food Research International
- Vol. 233 (Pt 2) , 119016
A large-scale survey of neuroactive agmatine in cheeses reveals six different technological/metabolic/environmental profiles associated with its accumulation
- 18 March 2026
- Published by Elsevier in Food Research International
- Vol. 233 (Pt 2) , 119016
Open AccessA large-scale survey of neuroactive agmatine in cheeses reveals six different technological/metabolic/environmental profiles associated with its accumulation
- Open Access
- 23 April 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (5) , 966
Isolation and Characterization of β-Phenylethylamine-Producing Lactic Acid Bacteria from Dairy Products
β-phenylethylamine (PEA) is a neuroactive trace amine synthesized by the enzymatic decarboxylation of phenylalanine. PEA is involved in the improvement of mood and attention. Functional foods enriched in this compound could, therefore, be of interest to the food industry. PEA is produced by microbial activity in certain foods, but usually only in small amounts. The search for PEA-producing microorganisms with good technological properties is thus a pre-requisite if such functional foods are to be produced. This work reports the isolation of thirty-three PEA-producing bacterial strains from samples of different dairy products. They belong to the genus Enterococcus, and the species Levilactobacillus brevis. Identified strains of Enterococcus durans were then selected for technological characterization. Some of them showed properties of interest. In this species, PEA was determined to be produced via the action of tyrosine decarboxylase, encoded by the gene tdcA. This implies that, apart from PEA, a concomitant production of tyramine, a toxic biogenic amine, was observed.
- 23 April 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (5) , 966
Open AccessIsolation and Characterization of β-Phenylethylamine-Producing Lactic Acid Bacteria from Dairy Products
β-phenylethylamine (PEA) is a neuroactive trace amine synthesized by the enzymatic decarboxylation of phenylalanine. PEA is involved in the improvement of mood and attention. Functional foods enriched in this compound could, therefore, be of interest to the food industry. PEA is produced by microbial activity in certain foods, but usually only in small amounts. The search for PEA-producing microorganisms with good technological properties is thus a pre-requisite if such functional foods are to be produced. This work reports the isolation of thirty-three PEA-producing bacterial strains from samples of different dairy products. They belong to the genus Enterococcus, and the species Levilactobacillus brevis. Identified strains of Enterococcus durans were then selected for technological characterization. Some of them showed properties of interest. In this species, PEA was determined to be produced via the action of tyrosine decarboxylase, encoded by the gene tdcA. This implies that, apart from PEA, a concomitant production of tyramine, a toxic biogenic amine, was observed.
- 23 August 2024
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 192, 114947
Do the biogenic amines ethylamine, ethanolamine and methylamine reach toxic concentrations in foods?
- 23 August 2024
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 192, 114947
Do the biogenic amines ethylamine, ethanolamine and methylamine reach toxic concentrations in foods?
- Open Access
Enterococcus faecium Bacteriophage vB_EfaH_163, a New Member of the Herelleviridae Family, Reduces the Mortality Associated with an E. faecium vanR Clinical Isolate in a Galleria mellonella Animal Model
The rise of antimicrobial resistant (AMR) bacteria is a major health concern, especially with regard to members of the ESKAPE group, to which vancomycin-resistant (VRE) Enterococcus faecium belongs. Phage therapy has emerged as a novel alternative for the treatment of AMR infections. This, however, relies on the isolation and characterisation of a large collection of phages. This work describes the exploration of human faeces as a source of new E. faecium-infecting phages. Phage vB_EfaH_163 was isolated and characterised at the microbiological, genomic, and functional levels. vB_EfaH_163 phage, a new member of Herelleviridae, subfamily Brockvirinae, has a dsDNA genome of 150,836 bp that does not harbour any virulence factors or antibiotic resistance genes. It infects a wide range of E. faecium strains of different origins, including VRE strains. Interestingly, it can also infect Enterococcus faecalis strains, even some that are linezolid-resistant. Its capacity to control the growth of a clinical VRE isolate was shown in broth culture and in a Galleria mellonella animal model. The discovery and characterisation of vB_EfaH_163 increases the number of phages that might be used therapeutically against AMR bacteria.
Open AccessEnterococcus faecium Bacteriophage vB_EfaH_163, a New Member of the Herelleviridae Family, Reduces the Mortality Associated with an E. faecium vanR Clinical Isolate in a Galleria mellonella Animal Model
The rise of antimicrobial resistant (AMR) bacteria is a major health concern, especially with regard to members of the ESKAPE group, to which vancomycin-resistant (VRE) Enterococcus faecium belongs. Phage therapy has emerged as a novel alternative for the treatment of AMR infections. This, however, relies on the isolation and characterisation of a large collection of phages. This work describes the exploration of human faeces as a source of new E. faecium-infecting phages. Phage vB_EfaH_163 was isolated and characterised at the microbiological, genomic, and functional levels. vB_EfaH_163 phage, a new member of Herelleviridae, subfamily Brockvirinae, has a dsDNA genome of 150,836 bp that does not harbour any virulence factors or antibiotic resistance genes. It infects a wide range of E. faecium strains of different origins, including VRE strains. Interestingly, it can also infect Enterococcus faecalis strains, even some that are linezolid-resistant. Its capacity to control the growth of a clinical VRE isolate was shown in broth culture and in a Galleria mellonella animal model. The discovery and characterisation of vB_EfaH_163 increases the number of phages that might be used therapeutically against AMR bacteria.